Zoekresultaten - 9 results
Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study.
global estimates of HCV prevalence, cascade of care, and disease burden were calculated based on 235 countries and territories. FINDINGS: Models were built for 110 countries or territories: 83 were ...
Prevalence Estimation Of HCV Among People Who Inject Drugs In Belgium Through Respondent Driven Sampling, Capture-Recapture And Multiplier Method
Publication Type: Scientific poster, presentation or proceeding Authors: E Plettinckx; L Van Baelen Source: International Network on Health and Hepatitis in Substance Users (INHSU), Arud Centres for ...
Challenges to Differentiate Hepatitis C Genotype 1 and 6: Results from A Field-Study in Cambodia.
Lynen; Steven Van Gucht; Benoît Kabamba Mukadi Source: Infect Dis Ther, Volume 9, Issue 3 (2020) Keywords: Genotype Hepatitis C Abstract: INTRODUCTION: We aim to report on results and challenges of ...
Low hepatitis C prevalence in Belgium: implications for treatment reimbursement and scale up.
order to guide decisions on DAA reimbursement. METHODS: Residual sera were collected through clinical laboratories. We collected data on age, sex and district. HCV antibody status was determined with ...
Hepatitis E virus serology and PCR: does the methodology matter?
(Altona RealStar®), and two optimized in-house real-time RT- PCR assays (according to Jothikumar et al., 2006 and Gyarmati et al., 2007). In addition, all three PCR assays were performed on 16 external ...
Rapport annuel 2016: virus de l'hépatite C (VHC)
en Belgique : on en a compté 744 409 en 2016, dont 42 % chez des patients pour lesquels aucun diagnostic VHC n’avait été effectué au cours des 9 dernières années. Le nombre de cas de VHC nouvellement ...
Diagnostic hepatitis C testing of people in treatment for substance use disorders in Belgium between 2011 and 2014: a cross-sectional study.
are scarce, and particularly for people who inject drugs. The current study refines the existing HCV estimates by focussing on diagnostic HCV testing practices for this population at risk. METHODS: The ...
Estimates of people who injected drugs within the last 12 months in Belgium based on a capture-recapture and multiplier method
on data from more than fifteen years ago and apply only to those who report ever injecting drugs. As a result, no reliable baseline data exist to determine the scale of services for PWID. Methods We ...
Stable HEV IgG seroprevalence in Belgium between 2006 and 2014.
trends in birth cohort-specific HEV seroprevalence and regional differences in Belgium. HEV IgG seroprevalence was analysed on national serum banks (1579 and 2087 samples for 2006 and 2014, respectively. ...